Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × OTHER_GOV × Vincristine × Clear all

Phase

Status

Suspended 1 Recruiting 1 Completed 1

Sponsor Class

OTHER 2 NIH 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1 Congenital Abnormalities 1

Interventions

zanubrutinib 1 osimertinib 1 Vincristine 1 Trastuzumab 1 Rituximab 1 Quality of Life 1 Prednisone 1 Nutritional Status 1 Microscopy, Confocal 1 Interviews as Topic 1 Heparin 1 Exercise 1 Erlotinib Hydrochloride 1 Epirubicin 1 Enoxaparin 1 Docetaxel 1 Cyclophosphamide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04668365 2025-04-25

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Suspended

Congenital Abnormalities, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡